Projects per year
Personal profile
Education
- 2011 Dphil Clinical Pharmacology Department, University of Oxford
- 2005 M.S., Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2019-2022 Director, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2017-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2017-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2017 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2013-2017 Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University
Research Interests
- Molecular mechanisms of tumorigenesis and translational medicine
- Toxicology and development of nanomaterials as drug delivery platform
- Protein post-translational modifications in cancer regulation
Fingerprint
Dive into the research topics where Er-Chieh Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
(教學實踐) 探討運用混成學習模式提升醫藥生技之臨床應用課程之學習成效
8/1/22 → 7/31/23
Project: A - Government Institution › d - Ministry of Education
-
應用發炎反應抑制劑對於致癌基因 HMGA2大量表現大腸癌之合併治療研究及調控分子機轉探討
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討HDAC/LSD1雙效抑制劑對KRAS突變及 5-FU抗藥性大腸癌細胞之治療及機轉研究
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
HDAC/LSD1雙效抑制劑於大腸癌治療之新藥開發與機轉研究
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
有機/無機混成奈米複合材料發展智慧型藥物傳輸系統以治療p53失效腫瘤之探討與評估
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
2-Mercaptoimidazole selectively etching and thiol-functionalized ZIF-8 metal–organic framework to serve as a multifaceted platform for radical scavenging and Au loading
Chen, Y. L., Lee, G. Y., Tang, D. W., Huang, K., Lo, P. Y., Huang, J. H., Cho, E. C. & Lee, K. C., Jan 2023, In: Materials Today Chemistry. 27, 101259.Research output: Contribution to journal › Article › peer-review
-
A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation
Lee, H. Y., Tang, D. W., Liu, C. Y. & Cho, E. C., Jan 25 2022, In: Chemico-Biological Interactions. 352, 109778.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Bio-Phenolic Resin Derived Porous Carbon Materials for High-Performance Lithium-Ion Capacitor
Cho, E. C., Chang-Jian, C. W., Lu, C. Z., Huang, J. H., Hsieh, T. H., Wu, N. J., Lee, K. C., Hsu, S. C. & Weng, H. C., Feb 1 2022, In: Polymers. 14, 3, 575.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Integration of PEG and PEI with graphene quantum dots to fabricate pH-responsive nanostars for colon cancer suppression in vitro and in vivo
Lee, G. Y., Lo, P. Y., Cho, E. C., Zheng, J. H., Li, M., Huang, J. H. & Lee, K. C., Jan 2022, In: FlatChem. 31, 100320.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Mitochondrial Factor C20orf7 Facilitates the EMT-Mediated Cancer Cell Migration and the Proliferation of Colon Cancer In Vitro and In Vivo
Liu, H. H., Lee, C. H., Hsieh, Y. C., Zheng, J. H., Liu, Y. R., Chang, C. H. & Cho, E. C., Nov 14 2022, In: Genes. 13, 11Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Ring size changes in the development of class I HDAC inhibitors
Lee, H. (Contributor), Cho, E. (Contributor), Tang, D. (Contributor) & Liu, C. (Contributor), figshare Academic Research System, Jan 1 2021
DOI: 10.6084/m9.figshare.14843703.v1, https://tandf.figshare.com/articles/journal_contribution/Ring_size_changes_in_the_development_of_class_I_HDAC_inhibitors/14843703/1
Dataset
-
Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
Lin, T. E. (Creator), Sung, L. (Creator), Chao, M. (Creator), Li, M. (Creator), Zheng, J. (Creator), Sung, T. (Creator), Hsieh, J. (Creator), Yang, C. (Creator), Lee, H. (Creator), Cho, E. (Creator) & Hsu, K. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17162118.v1, https://tandf.figshare.com/articles/journal_contribution/Structure-based_virtual_screening_and_biological_evaluation_of_novel_small-molecule_BTK_inhibitors/17162118/1
Dataset